Xylyx Bio, Inc.
- Biotech or pharma, therapeutic R&D
Xylyx Bio’s first-in-class organ rehabilitation system salvages human donor organs (lung, liver, heart, kidney) to enable significantly more life-saving transplants. Compassionate use lung transplant scheduled for year-end 2024.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}